Concepedia

Aleksandr Suvorov

AS

Statistics

Publications

12

Citations

2.9K

H-Index

11

Active since

2014

Affiliations

The First Republican Clinical Hospital of the Ministry of Health of the Udmurt Republic(Current)

Wilhelminen Hospital

University of Ostrava

Nantes Université

Hospital Clínic de Barcelona

Aleksandr Suvorov is an author at The First Republican Clinical Hospital of the Ministry of Health of the Udmurt Republic specializing in medicine, multiple myeloma, and hematologic malignancy therapy.

Publications per year

2014–2017

12

Publications

12

Carfilzomib, Lenalidomide, and Dexamethasone for Relapsed Multiple Myeloma

A. Keith Stewart, S. Vincent Rajkumar, Meletios Α. Dimopoulos et al. · New England Journal of Medicine · 2014 · 1.3K citations · Full text

, , +16

Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicentre study

Meletios Α. Dimopoulos, Philippe Moreau, Antonio Palumbo et al. · The Lancet Oncology · 2015 · 849 citations · Full text

, , +17

Pacritinib versus best available therapy for the treatment of myelofibrosis irrespective of baseline cytopenias (PERSIST-1): an international, randomised, phase 3 trial

Ruben A. Mesa, Alessandro M. Vannucchi, Adam J. Mead et al. · The Lancet Haematology · 2017 · 314 citations · Full text

, , +9

Impact of prior treatment on patients with relapsed multiple myeloma treated with carfilzomib and dexamethasone vs bortezomib and dexamethasone in the phase 3 ENDEAVOR study

Philippe Moreau, D. Joshua, W-J Chng et al. · Leukemia · 2016 · 78 citations · Full text

, , +15

Carfilzomib, lenalidomide, and dexamethasone in patients with relapsed multiple myeloma categorised by age: secondary analysis from the phase 3 ASPIRE study

Meletios Α. Dimopoulos, A. Keith Stewart, Tamás Masszi et al. · British Journal of Haematology · 2017 · 67 citations · Full text

, , +15

1–5 of 12